Deep tissue sequencing improves genetic diagnostic yield in focal cortical dysplasia
Abstract
Focal cortical dysplasias (FCDs) are malformations of cortical development associated with drug-resistant focal epilepsy. We analysed surgical tissue from 28 consecutive cases recruited from adult and pediatric epilepsy surgery programs. We performed high-depth sequencing of lesional tissue, validated somatic variants using droplet digital PCR, and investigated genotype-phenotype correlations. A pathogenic or likely pathogenic variant was detected in 71% (n=20/28) of cases. Of these, six cases with FCDIIa or FCDIIb had germline variants in NPRL3 (n=4) or DEPDC5 (n=2). Somatic variants were identified in 50% (n=14/28) of cases. The genetic yield for FCDIIb was 85% of cases having a pathogenic mTOR pathway variant detected (n=12/14), and for FCDIIa 66% (n=6/9). This was achieved through high depth sequencing approaches that allowed detection of somatic variants with very low (down to 0.4%) variant allele fractions (VAFs). No pathogenic variants were detected in 3 cases with FCDI. 70% (n=18/26) of the cases with ≥12 months follow up experienced a favourable seizure outcome (Engel 1–2) following surgery. Of note, n=10 patients required repeat surgery to resect residual dysplasia. Determining a genetic diagnosis reveals aetiology and paves the way to precision therapies that may benefit those with FCD who do not respond to current treaments.
Related articles
Related articles are currently not available for this article.